Leadership Overview
Wockhardt has 9 executives leading key functions including strategy, finance, marketing, people, operations, and medical affairs.
Driven by a commitment to global health, Wockhardt is dedicated to manufacturing and marketing pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients, and vaccines, impacting healthcare worldwide.
Driven by a commitment to global health, Wockhardt is dedicated to manufacturing and marketing pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients, and vaccines, impacting healthcare worldwide.
Leadership Roles at Wockhardt
Nitin Tirodkar - Chief Executive Officer
Nitin Tirodkar, the Chief Executive Officer at Wockhardt, directs the company's overall strategic vision and operational execution. Overseeing all business units, Tirodkar ensures alignment with Wockhardt's mission to provide accessible pharmaceutical and bio-pharmaceutical solutions globally. This leadership role involves driving innovation in the development of active pharmaceutical ingredients and vaccines, critical components of the company's diverse product portfolio. By fostering cross-functional collaboration, Nitin Tirodkar enhances the efficiency of manufacturing processes and the effectiveness of marketing strategies. The Chief Executive Officer's focus remains on expanding market reach and solidifying Wockhardt's position as a leader in the global pharmaceutical landscape, ensuring sustainable growth and a robust pipeline of life-saving treatments.
Jayant Dalal - Chief Financial Officer
Jayant Dalal, the Chief Financial Officer at Wockhardt, manages the company's financial health and strategic fiscal planning. Dalal oversees all financial operations, including accounting, budgeting, and financial reporting, ensuring compliance with global regulatory standards. This critical position involves optimizing capital allocation for research and development of new pharmaceutical and bio-pharmaceutical formulations, as well as active pharmaceutical ingredients. Jayant Dalal drives initiatives to enhance financial efficiency across manufacturing and marketing operations, directly supporting Wockhardt's expansion into new international markets. The Chief Financial Officer's expertise is vital in navigating complex financial landscapes, securing investments, and maintaining the company's strong financial foundation to support its mission of improving global healthcare outcomes.
Vijay Sharma - President & Director
Vijay Sharma, the President & Director at Wockhardt, holds significant responsibility for guiding the company's strategic direction and operational oversight. Sharma contributes to the executive leadership team's efforts in advancing Wockhardt's global presence in pharmaceutical and bio-pharmaceutical manufacturing, active pharmaceutical ingredients, and vaccine production. This role involves ensuring that corporate governance and strategic initiatives are effectively implemented across all business functions. Vijay Sharma's leadership supports the company's commitment to innovation and quality in healthcare solutions. The President & Director's involvement is key to maintaining Wockhardt's reputation for excellence and its ongoing mission to improve patient outcomes through advanced medical products.
Skhera Khera - President
Skhera Khera, the President at Wockhardt, plays a pivotal role in overseeing key operational segments and driving strategic growth initiatives. Khera directs efforts to enhance the manufacturing and marketing of Wockhardt's diverse product lines, including pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients, and vaccines. This leadership position involves fostering strong relationships with stakeholders and ensuring operational efficiency across various business units. Skhera Khera's contributions are essential in expanding Wockhardt's global footprint and reinforcing its commitment to delivering high-quality healthcare solutions. The President's focus on strategic execution supports the company's overarching mission to make a significant impact on global health.
Avijit Deb - President and CDO
Avijit Deb, the President and CDO at Wockhardt, drives the company's digital transformation and strategic growth initiatives. Deb oversees the integration of advanced digital technologies across all business functions, enhancing operational efficiency and market responsiveness for Wockhardt's pharmaceutical and bio-pharmaceutical products, active pharmaceutical ingredients, and vaccines. This leadership role is critical in leveraging data analytics and digital platforms to optimize manufacturing processes and expand market reach. Avijit Deb champions innovation in product development and customer engagement, ensuring Wockhardt remains at the forefront of the global healthcare industry. The President and CDO's vision is instrumental in shaping Wockhardt's future and its continued commitment to improving global health outcomes.
Nemichand Jain - Chief Marketing Officer
Nemichand Jain, the Chief Marketing Officer at Wockhardt, spearheads the strategic development and execution of all marketing initiatives. Jain directs the promotion of Wockhardt's extensive range of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients, and vaccines across diverse global markets. This role involves identifying emerging market trends and consumer needs to inform product development and positioning strategies. Nemichand Jain oversees the creation and implementation of impactful campaigns that enhance brand visibility and drive market penetration for Wockhardt's innovative healthcare solutions. The Chief Marketing Officer's leadership ensures that the company's commitment to improving global health is effectively communicated, fostering strong relationships with healthcare professionals and patients worldwide.
Bala Aiyaswamy - Chief People Officer
Bala Aiyaswamy, the Chief People Officer at Wockhardt, leads the strategic direction of human capital management and organizational development. Aiyaswamy oversees all aspects of talent acquisition, employee engagement, and performance management, ensuring a robust and motivated workforce. This position is crucial for cultivating a culture that supports Wockhardt's mission in pharmaceutical and bio-pharmaceutical innovation, active pharmaceutical ingredients, and vaccine development. Bala Aiyaswamy drives initiatives to foster professional growth and development, aligning employee capabilities with the company's strategic objectives and global expansion plans. The Chief People Officer's focus on nurturing talent is fundamental to Wockhardt's continued success in delivering high-quality healthcare solutions worldwide.
Prithwijit Kundu - Chief Medical Officer, NCE Ndd
Prithwijit Kundu, the Chief Medical Officer, NCE Ndd at Wockhardt, leads the medical affairs strategy and clinical development for new chemical entities and novel drug delivery systems. Kundu oversees the scientific evaluation and clinical validation of Wockhardt's innovative pharmaceutical and bio-pharmaceutical products, ensuring their safety and efficacy. This critical role involves guiding research efforts and collaborating with regulatory bodies to bring groundbreaking treatments to market. Prithwijit Kundu's expertise is vital in advancing Wockhardt's pipeline of active pharmaceutical ingredients and vaccines, contributing significantly to the company's mission of addressing unmet medical needs globally. The Chief Medical Officer's dedication to scientific excellence drives Wockhardt's commitment to improving patient care worldwide.
Devindar Mishra - Mareketing
Devindar Mishra, the Mareketing at Wockhardt, focuses on advancing the company's market presence and product promotion strategies. Mishra is involved in developing and implementing targeted marketing campaigns for Wockhardt's pharmaceutical and bio-pharmaceutical products, active pharmaceutical ingredients, and vaccines. This role contributes to understanding market dynamics and consumer needs within the global healthcare sector. Devindar Mishra's efforts support the effective communication of Wockhardt's value proposition to healthcare professionals and potential customers. The Mareketing's dedication to strategic outreach is integral to reinforcing Wockhardt's mission of improving health outcomes worldwide through its innovative offerings.
Explore Leadership Teams in Manufacturing
Headquartered in Hyderabad, India, Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company providing affordable and innovative medicines for healthier lives.
Company Leadership
RD
PB
DS
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Company Leadership ES
SS
BH
Proxima Research International LLC is a company that operates in the Pharmaceuticals industry. It employs 500to999 people and has 25Mto50M of revenue. The company is headquartered in Fort Lauderdale, Florida.
Company Leadership EK
OB
NT
AA
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.
Company Leadership SR
LB
Frequently Asked Questions Regarding Wockhardt Top Executives and Leadership Team
